FDA Approved Products
4,491 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
DOPAMINE HYDROCHLORIDE
dopamine hydrochloride
LOE Approaching
Pfizer
INJECTION · INJECTABLE
hemodynamic status in patients in shock
1981
NDA30/100
DOPAMINE HYDROCHLORIDE
dopamine hydrochloride
LOE Approaching
Medica Corp
INJECTION · INJECTABLE
1981
NDA30/100
DOPAMINE HYDROCHLORIDE
dopamine hydrochloride
LOE Approaching
Baxter
INJECTION · INJECTABLE
1981
NDA30/100
DOPAMINE HYDROCHLORIDE AND DEXTROSE 5%
dopamine hydrochloride
LOE Approaching
B. Braun
INJECTION · INJECTABLE
1986
NDA30/100
DOPAMINE HYDROCHLORIDE AND DEXTROSE 5% IN PLASTIC CONTAINER
dopamine hydrochloride
LOE Approaching
B. Braun
INJECTION · INJECTABLE
1986
NDA30/100
DOPAMINE HYDROCHLORIDE IN DEXTROSE 5%
dopamine hydrochloride
LOE Approaching
Pfizer
INJECTION · INJECTABLE
1995
NDA30/100
DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
dopamine hydrochloride
LOE Approaching
Baxter
INJECTION · INJECTABLE
1987
NDA30/100
DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
dopamine hydrochloride in dextrose
LOE Approaching
Pfizer
INJECTION · INJECTABLE
hemodynamic status in patients in shock
1983
NDA30/100
DOPAR
levodopa
LOE Approaching
Takeda
ORAL · TABLET
Parkinson's disease
1970
NDA30/100
DOPRAM
doxapram hydrochloride
LOE Approaching
Hikma
INJECTION · INJECTABLE
depressionchronic obstructive pulmonary disease
1965
NDA30/100
DORIBAX
doripenem
LOE Approaching
Shionogi
INTRAVENOUS · INJECTABLE
2007
NDA30/100
DORIDEN
glutethimide
LOE Approaching
Sanofi
ORAL · CAPSULE
1957
NDA30/100
DORYX
doxycycline hyclate
LOE Approaching
ORAL · CAPSULE, DELAYED RELEASE
Rocky Mountain spotted fevertyphus fever+19
1985
NDA30/100
DOSTINEX
cabergoline
LOE Approaching
Pfizer
ORAL · TABLET
hyperprolactinemic disorderseither idiopathic+1
1996
NDA30/100
DOVONEX
calcipotriene
LOE Approaching
Leo Pharma
TOPICAL · CREAM
plaque psoriasispsoriasis
1996
NDA30/100
DOVONEX
calcipotriene
LOE Approaching
PleoPharma
TOPICAL · SOLUTION
plaque psoriasispsoriasis
1997
NDA30/100
DOVONEX
calcipotriene
LOE Approaching
Leo Pharma
TOPICAL · OINTMENT
plaque psoriasis in adultspsoriasis
1993
NDA30/100
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
LOE Approaching
ORAL · CAPSULE
major depressive disorder (MDD) in adults ( )
1972
NDA30/100
DOXIL (LIPOSOMAL)
doxorubicin hydrochloride liposome
LOE Approaching
Baxter
INJECTION · INJECTABLE, LIPOSOMAL
recurred after platinum-based chemotherapyAIDS-related Kaposi's sarcoma in patients after failure of prior systemic chemotherapy+3
1995
NDA30/100
DOXORUBICIN HYDROCHLORIDE
doxorubicin hydrochloride
LOE Approaching
Pfizer
INJECTION · INJECTABLE
recurred after platinum-based chemotherapyAIDS-related Kaposi's sarcoma in patients after failure of prior systemic chemotherapy+3
1974
NDA30/100
DOXORUBICIN HYDROCHLORIDE
doxorubicin hydrochloride
LOE Approaching
Pfizer
INJECTION · INJECTABLE
breast cancerleukemia+1
1987
NDA30/100
DRAXIMAGE DTPA
kit for the preparation of technetium tc 99m pentetate
LOE Approaching
Jubilant Therapeutics
INJECTION · INJECTABLE
pulmonary embolism
1989
NDA30/100
DRAXIMAGE MDP-10
technetium tc 99m medronate
LOE Approaching
Jubilant Therapeutics
INJECTION · INJECTABLE
1978
NDA30/100
DRAXIMAGE MDP-25
technetium tc 99m medronate
LOE Approaching
Jubilant Therapeutics
INJECTION · INJECTABLE
1978
NDA30/100